Paris, France

Martine Latta

This inventor holds 3 USPTO granted patents. Top assignee: Genetica. Active years: 1990-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Martine Latta. Retrieved from https://idiyas.com/inventor/martine-latta-5am2g417

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 3.5

ph-index = 3

Forward Citations = 115(Granted Patents)


Company Filing History:


Years Active: 1990-1993

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Martine Latta: Innovator in Human Serum Albumin Production

Introduction

Martine Latta is a prominent inventor based in Paris, France. She has made significant contributions to the field of biotechnology, particularly in the production of human serum albumin. With a total of 3 patents to her name, her work has garnered attention for its innovative approaches and applications.

Latest Patents

Latta's latest patents focus on the process for the preparation of mature human serum albumin. This involves producing mature human serum albumin from a microbiological route in the form of a fused protein known as 'pseudo-pro-HSA,' which contains an N-terminal peptide elongation. This innovative method enhances the efficiency and effectiveness of serum albumin production.

Career Highlights

Martine Latta has established herself as a key figure in her field through her work at Genetica. Her expertise and dedication have led to advancements in biopharmaceuticals, particularly in the area of serum albumin, which is crucial for various medical applications.

Collaborations

Latta has collaborated with notable professionals in her field, including Jean-Francois Mayaux and Paolo Sarmientos. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Martine Latta's innovative work in the production of human serum albumin showcases her significant contributions to biotechnology. Her patents and collaborations reflect her commitment to advancing medical science and improving health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…